Mark Kaye

Mark Kaye

DirectoratElevance Health· In proxies 2023–2025

Pay in FY2025+16% from the year before

Mark Kaye was paid $8.0M in FY2025 (Dec), up 16%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Elevance Health proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. CONMEDPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  2. Elevance HealthPublic company · 3 yr
    • EVP and Chief Financial Officer (CFO)2023 – Present · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?